Spoken Alpha
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc is a Healthcare company operating in Biotechnology with a $1.03B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GLUE.
$ curl https://api.spokenalpha.com/v1/companies/GLUEFAQ
Spoken Alpha indexes GLUE's earnings call transcripts at https://spokenalpha.com/companies/GLUE. Each call links to attributed speakers and parsed analyst Q&A. Monte Rosa Therapeutics, Inc.'s own investor relations page is at https://ir.monterosatx.com/.
Monte Rosa Therapeutics, Inc. (GLUE) held its most recent earnings call on 2025-03-20, covering fiscal Q4 2024.
Monte Rosa Therapeutics, Inc. (GLUE) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $0.02 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-0.43 | $-0.25 | -72.0% | $9.0M | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-0.45 | $-0.38 | -18.4% | $4.2M | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $-0.55 | $-0.33 | -67.6% | $2.8M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-0.33 | $-0.35 | +5.7% | $12.8M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.15 | $-0.31 | +51.6% | $23.2M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $0.57 | $-0.32 | +100.0% | $84.9M | — | — | EODHD |
| Q4 FY2024 | 2025-03-19 | $-0.36 | $0.18 | -100.0% | $60.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.29 | $-0.47 | +38.3% | $9.2M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.43 | $-0.54 | +20.4% | $4.7M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.53 | $-0.58 | +8.6% | $1.1M | — | — | EODHD |
| Q4 FY2023 | 2024-03-13 | $-0.58 | $-0.33 | -75.8% | $8.8M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.70 | $-0.74 | +5.4% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.71 | $-0.69 | -2.9% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.65 | $-0.68 | +4.4% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-15 | $-0.63 | $-0.62 | -1.6% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.58 | $-0.59 | +1.7% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-0.57 | $-0.47 | -21.3% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-10 | $-0.51 | $-0.54 | +5.6% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-28 | $-0.93 | $-0.50 | -86.0% | $0 | — | — | EODHD |
Source: EODHD. GLUE reported actuals as published; sparse fields render as —.